世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ヒト用ワクチンの世界市場 2022-2026


Global Human Vaccine Market 2022-2026

ヒト用ワクチンの世界市場 2022-2026 Technavioはヒト用ワクチン市場を監視しており、2022年から2026年の間に203億7000万ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、ヒト... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2022年5月5日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら
120 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

ヒト用ワクチンの世界市場 2022-2026
Technavioはヒト用ワクチン市場を監視しており、2022年から2026年の間に203億7000万ドルの成長が見込まれ、予測期間中にCAGR7.73%で加速しています。当レポートでは、ヒト用ワクチン市場の全体分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新動向と推進要因、市場全体の環境に関する最新の分析を提供しています。市場は、ワクチン分野への投資の増加、政府による公的な予防接種プログラム、ワクチンに関する情報への一般市民のアクセスの改善によって牽引されています。
ヒト用ワクチン市場の分析には、投与経路セグメントや地理的状況も含まれます。
Technavioのヒト用ワクチン市場は、以下のように区分されています。
投与経路別
- 筋肉内
- 皮下投与
- 経口
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、高所得国および発展途上国におけるワクチン需要の多様性が、今後数年間のヒト用ワクチン市場の成長を促進する主要な理由の1つであると特定しています。また、新規ワクチンの研究開発およびワクチン送達システムの進歩は、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。当社のヒト用ワクチン市場に関するレポートは、以下の分野を対象としています。
- ヒト用ワクチン市場のサイジング
- ヒト用ワクチン市場の予測
- ヒト用ワクチン市場の産業分析
Technavioの堅牢なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、アステラス製薬株式会社、AstraZeneca Plc、Bavarian Nordic AS、Bharat Biotech Ltd、BioNTech SE、CanSino Biologics Inc、CSL Ltd、Daiichi Sankyo Co., Inc.など、複数の主要ヒトワクチン市場ベンダーに関する詳細分析を提供しています。Ltd.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc、Gradalis Inc.、Inovio Pharmaceuticals Inc.、Johnson and Johnson、Merck and Co.Inc.、三菱ケミカルホールディングス株式会社、Moderna Inc.、Novavax Inc.、Pfizer Inc.、Sanofi、Serum Institute of India Pvt. Ltd.の7社です。また、ヒトワクチン市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/human-vaccine-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る


目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Intramuscular - Market size and forecast 2021-2026
o Exhibit 28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
o 5.4 Subcutaneous - Market size and forecast 2021-2026
o Exhibit 32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
o 5.5 Oral - Market size and forecast 2021-2026
o Exhibit 36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Route of Administration
o Exhibit 44: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Bavarian Nordic AS
o Exhibit 93: Bavarian Nordic AS - Overview
o Exhibit 94: Bavarian Nordic AS - Product / Service
o Exhibit 95: Bavarian Nordic AS - Key news
o Exhibit 96: Bavarian Nordic AS - Key offerings
o 10.4 CSL Ltd.
o Exhibit 97: CSL Ltd. - Overview
o Exhibit 98: CSL Ltd. - Business segments
o Exhibit 99: CSL Ltd. - Key news
o Exhibit 100: CSL Ltd. - Key offerings
o Exhibit 101: CSL Ltd. - Segment focus
o 10.5 Daiichi Sankyo Co. Ltd.
o Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 107: GlaxoSmithKline Plc - Overview
o Exhibit 108: GlaxoSmithKline Plc - Business segments
o Exhibit 109: GlaxoSmithKline Plc - Key news
o Exhibit 110: GlaxoSmithKline Plc - Key offerings
o Exhibit 111: GlaxoSmithKline Plc - Segment focus
o 10.7 Inovio Pharmaceuticals Inc.
o Exhibit 112: Inovio Pharmaceuticals Inc. - Overview
o Exhibit 113: Inovio Pharmaceuticals Inc. - Product / Service
o Exhibit 114: Inovio Pharmaceuticals Inc. - Key offerings
o 10.8 Merck and Co. Inc.
o Exhibit 115: Merck and Co. Inc. - Overview
o Exhibit 116: Merck and Co. Inc. - Business segments
o Exhibit 117: Merck and Co. Inc. - Key news
o Exhibit 118: Merck and Co. Inc. - Key offerings
o Exhibit 119: Merck and Co. Inc. - Segment focus
o 10.9 Mitsubishi Chemical Holdings Corp.
o Exhibit 120: Mitsubishi Chemical Holdings Corp. - Overview
o Exhibit 121: Mitsubishi Chemical Holdings Corp. - Business segments
o Exhibit 122: Mitsubishi Chemical Holdings Corp. - Key offerings
o Exhibit 123: Mitsubishi Chemical Holdings Corp. - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 124: Pfizer Inc. - Overview
o Exhibit 125: Pfizer Inc. - Product / Service
o Exhibit 126: Pfizer Inc. - Key news
o Exhibit 127: Pfizer Inc. - Key offerings
o 10.11 Sanofi
o Exhibit 128: Sanofi - Overview
o Exhibit 129: Sanofi - Business segments
o Exhibit 130: Sanofi - Key news
o Exhibit 131: Sanofi - Key offerings
o Exhibit 132: Sanofi - Segment focus
o 10.12 Serum Institute of India Pvt. Ltd.
o Exhibit 133: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 134: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 135: Serum Institute of India Pvt. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 136: Inclusions checklist
o Exhibit 137: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 138: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 139: Research methodology
o Exhibit 140: Validation techniques employed for market sizing
o Exhibit 141: Information sources
o 11.5 List of abbreviations
o Exhibit 142: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Route of Administration ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Bavarian Nordic AS - Overview
Exhibits94: Bavarian Nordic AS - Product / Service
Exhibits95: Bavarian Nordic AS - Key news
Exhibits96: Bavarian Nordic AS - Key offerings
Exhibits97: CSL Ltd. - Overview
Exhibits98: CSL Ltd. - Business segments
Exhibits99: CSL Ltd. - Key news
Exhibits100: CSL Ltd. - Key offerings
Exhibits101: CSL Ltd. - Segment focus
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: GlaxoSmithKline Plc - Overview
Exhibits108: GlaxoSmithKline Plc - Business segments
Exhibits109: GlaxoSmithKline Plc - Key news
Exhibits110: GlaxoSmithKline Plc - Key offerings
Exhibits111: GlaxoSmithKline Plc - Segment focus
Exhibits112: Inovio Pharmaceuticals Inc. - Overview
Exhibits113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits114: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Overview
Exhibits116: Merck and Co. Inc. - Business segments
Exhibits117: Merck and Co. Inc. - Key news
Exhibits118: Merck and Co. Inc. - Key offerings
Exhibits119: Merck and Co. Inc. - Segment focus
Exhibits120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits123: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits124: Pfizer Inc. - Overview
Exhibits125: Pfizer Inc. - Product / Service
Exhibits126: Pfizer Inc. - Key news
Exhibits127: Pfizer Inc. - Key offerings
Exhibits128: Sanofi - Overview
Exhibits129: Sanofi - Business segments
Exhibits130: Sanofi - Key news
Exhibits131: Sanofi - Key offerings
Exhibits132: Sanofi - Segment focus
Exhibits133: Serum Institute of India Pvt. Ltd. - Overview
Exhibits134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits135: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations

 

ページTOPに戻る


 

Summary

Global Human Vaccine Market 2022-2026
Technavio has been monitoring the human vaccine market and it is poised to grow by $ 20.37 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period. Our report on the human vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in investments in vaccines segment, public immunization programs funded by governments, and improved public access to information about vaccines.
The human vaccine market analysis includes the route of administration segment and geographic landscape.
Technavio's human vaccine market is segmented as below:
By Route of Administration
• Intramuscular
• Subcutaneous
• Oral
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the varied demand for vaccines in high-income and developing countries as one of the prime reasons driving the human vaccine market growth during the next few years. Also, R and D of novel vaccines and advancements in vaccine delivery systems will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on human vaccine market covers the following areas:
• Human vaccine market sizing
• Human vaccine market forecast
• Human vaccine market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading human vaccine market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BioNTech SE, CanSino Biologics Inc., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson, Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Moderna Inc., Novavax Inc., Pfizer Inc., Sanofi, and Serum Institute of India Pvt. Ltd. Also, the human vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/human-vaccine-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Route of Administration
o 5.1 Market segments
o Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
o 5.2 Comparison by Route of Administration
o Exhibit 26: Chart on Comparison by Route of Administration
o Exhibit 27: Data Table on Comparison by Route of Administration
o 5.3 Intramuscular - Market size and forecast 2021-2026
o Exhibit 28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
o 5.4 Subcutaneous - Market size and forecast 2021-2026
o Exhibit 32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
o 5.5 Oral - Market size and forecast 2021-2026
o Exhibit 36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Oral - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Route of Administration
o Exhibit 44: Market opportunity by Route of Administration ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 78: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 Bavarian Nordic AS
o Exhibit 93: Bavarian Nordic AS - Overview
o Exhibit 94: Bavarian Nordic AS - Product / Service
o Exhibit 95: Bavarian Nordic AS - Key news
o Exhibit 96: Bavarian Nordic AS - Key offerings
o 10.4 CSL Ltd.
o Exhibit 97: CSL Ltd. - Overview
o Exhibit 98: CSL Ltd. - Business segments
o Exhibit 99: CSL Ltd. - Key news
o Exhibit 100: CSL Ltd. - Key offerings
o Exhibit 101: CSL Ltd. - Segment focus
o 10.5 Daiichi Sankyo Co. Ltd.
o Exhibit 102: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 103: Daiichi Sankyo Co. Ltd. - Business segments
o Exhibit 104: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 105: Daiichi Sankyo Co. Ltd. - Key offerings
o Exhibit 106: Daiichi Sankyo Co. Ltd. - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 107: GlaxoSmithKline Plc - Overview
o Exhibit 108: GlaxoSmithKline Plc - Business segments
o Exhibit 109: GlaxoSmithKline Plc - Key news
o Exhibit 110: GlaxoSmithKline Plc - Key offerings
o Exhibit 111: GlaxoSmithKline Plc - Segment focus
o 10.7 Inovio Pharmaceuticals Inc.
o Exhibit 112: Inovio Pharmaceuticals Inc. - Overview
o Exhibit 113: Inovio Pharmaceuticals Inc. - Product / Service
o Exhibit 114: Inovio Pharmaceuticals Inc. - Key offerings
o 10.8 Merck and Co. Inc.
o Exhibit 115: Merck and Co. Inc. - Overview
o Exhibit 116: Merck and Co. Inc. - Business segments
o Exhibit 117: Merck and Co. Inc. - Key news
o Exhibit 118: Merck and Co. Inc. - Key offerings
o Exhibit 119: Merck and Co. Inc. - Segment focus
o 10.9 Mitsubishi Chemical Holdings Corp.
o Exhibit 120: Mitsubishi Chemical Holdings Corp. - Overview
o Exhibit 121: Mitsubishi Chemical Holdings Corp. - Business segments
o Exhibit 122: Mitsubishi Chemical Holdings Corp. - Key offerings
o Exhibit 123: Mitsubishi Chemical Holdings Corp. - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 124: Pfizer Inc. - Overview
o Exhibit 125: Pfizer Inc. - Product / Service
o Exhibit 126: Pfizer Inc. - Key news
o Exhibit 127: Pfizer Inc. - Key offerings
o 10.11 Sanofi
o Exhibit 128: Sanofi - Overview
o Exhibit 129: Sanofi - Business segments
o Exhibit 130: Sanofi - Key news
o Exhibit 131: Sanofi - Key offerings
o Exhibit 132: Sanofi - Segment focus
o 10.12 Serum Institute of India Pvt. Ltd.
o Exhibit 133: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 134: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 135: Serum Institute of India Pvt. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 136: Inclusions checklist
o Exhibit 137: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 138: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 139: Research methodology
o Exhibit 140: Validation techniques employed for market sizing
o Exhibit 141: Information sources
o 11.5 List of abbreviations
o Exhibit 142: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Route of Administration
Exhibits27: Data Table on Comparison by Route of Administration
Exhibits28: Chart on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Intramuscular - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Intramuscular - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Subcutaneous - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Subcutaneous - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Route of Administration ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: Bavarian Nordic AS - Overview
Exhibits94: Bavarian Nordic AS - Product / Service
Exhibits95: Bavarian Nordic AS - Key news
Exhibits96: Bavarian Nordic AS - Key offerings
Exhibits97: CSL Ltd. - Overview
Exhibits98: CSL Ltd. - Business segments
Exhibits99: CSL Ltd. - Key news
Exhibits100: CSL Ltd. - Key offerings
Exhibits101: CSL Ltd. - Segment focus
Exhibits102: Daiichi Sankyo Co. Ltd. - Overview
Exhibits103: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits104: Daiichi Sankyo Co. Ltd. - Key news
Exhibits105: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits106: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits107: GlaxoSmithKline Plc - Overview
Exhibits108: GlaxoSmithKline Plc - Business segments
Exhibits109: GlaxoSmithKline Plc - Key news
Exhibits110: GlaxoSmithKline Plc - Key offerings
Exhibits111: GlaxoSmithKline Plc - Segment focus
Exhibits112: Inovio Pharmaceuticals Inc. - Overview
Exhibits113: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits114: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits115: Merck and Co. Inc. - Overview
Exhibits116: Merck and Co. Inc. - Business segments
Exhibits117: Merck and Co. Inc. - Key news
Exhibits118: Merck and Co. Inc. - Key offerings
Exhibits119: Merck and Co. Inc. - Segment focus
Exhibits120: Mitsubishi Chemical Holdings Corp. - Overview
Exhibits121: Mitsubishi Chemical Holdings Corp. - Business segments
Exhibits122: Mitsubishi Chemical Holdings Corp. - Key offerings
Exhibits123: Mitsubishi Chemical Holdings Corp. - Segment focus
Exhibits124: Pfizer Inc. - Overview
Exhibits125: Pfizer Inc. - Product / Service
Exhibits126: Pfizer Inc. - Key news
Exhibits127: Pfizer Inc. - Key offerings
Exhibits128: Sanofi - Overview
Exhibits129: Sanofi - Business segments
Exhibits130: Sanofi - Key news
Exhibits131: Sanofi - Key offerings
Exhibits132: Sanofi - Segment focus
Exhibits133: Serum Institute of India Pvt. Ltd. - Overview
Exhibits134: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits135: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits136: Inclusions checklist
Exhibits137: Exclusions checklist
Exhibits138: Currency conversion rates for US$
Exhibits139: Research methodology
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Information sources
Exhibits142: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/08 10:26

154.13 円

166.76 円

202.76 円

ページTOPに戻る